檢索結果 - Suzanne Shusterman

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

    A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma 由 Deepa Kolaseri Krishnadas, Suzanne Shusterman, Fanqi Bai, Lisa Diller, Janice E. Sullivan, Alexandra Cheerva, Rani E. George, Kenneth G. Lucas

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium

    Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium 由 Richard Aplenc, Susan M. Blaney, Lewis C. Strauss, Frank M. Balis, Suzanne Shusterman, Ashish M. Ingle, Shruti Agrawal, Junfeng Sun, James R. Wright, Peter C. Adamson

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

    Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study 由 Katherine K. Matthay, Alekist Quach, John P. Huberty, Benjamin L. Franc, Randall A. Hawkins, Hollie Jackson, Susan Groshen, Suzanne Shusterman, Gregory A. Yanik, Janet Veatch, Patricia Brophy, Judith G. Villablanca, John M. Maris

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

    Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study 由 Steven G. DuBois, Suzanne Shusterman, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Bing Wu, Sylvain Baruchel, Julia Glade Bender, Percy Ivy, Holcombe E. Grier, Peter C. Adamson, Susan M. Blaney

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

    Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study 由 Jane E. Minturn, Audrey E. Evans, Judith G. Villablanca, Gregory A. Yanik, Julie R. Park, Suzanne Shusterman, Susan Groshen, Edward T. Hellriegel, Debra M. Bensen-Kennedy, Katherine K. Matthay, Garrett M. Brodeur, John M. Maris

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer

    Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer 由 Jennifer W. Mack, Hajime Uno, Clare J. Twist, Rochelle Bagatell, Abby R. Rosenberg, Araz Marachelian, Meaghan Granger, Julia Glade Bender, Justin N. Baker, Julie R. Park, Susan L. Cohn, Jorge Hernández Fernández, Lisa Diller, Suzanne Shusterman

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Unrealistic parental expectations for cure in poor‐prognosis childhood cancer

    Unrealistic parental expectations for cure in poor‐prognosis childhood cancer 由 Jennifer W. Mack, Angel M. Cronin, Hajime Uno, Suzanne Shusterman, Clare J. Twist, Rochelle Bagatell, Abby R. Rosenberg, Araz Marachelian, Meaghan Granger, Julia Glade Bender, Justin N. Baker, Julie Park, Susan L. Cohn, Alyssa Levine, Sarah Taddei, Lisa Diller

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

    Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy 由 David Delgado, Jacquelyn A. Hank, Jill Kolesar, David Lorentzen, Jacek Gan, Songwon Seo, KyungMann Kim, Suzanne Shusterman, Stephen D. Gillies, Ralph A. Reisfeld, Richard K. Yang, Brian Gadbaw, Kenneth DeSantes, Wendy B. London, Robert C. Seeger, John M. Maris, Paul M. Sondel

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

    Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study 由 Suzanne Shusterman, Wendy B. London, Stephen D. Gillies, Jacquelyn A. Hank, Stephan D. Voss, Robert C. Seeger, C. Patrick Reynolds, Jennifer Kimball, Mark R. Albertini, Barrett Wagner, Jacek Gan, Jens C. Eickhoff, Kenneth DeSantes, Susan L. Cohn, Toby T. Hecht, Brian Gadbaw, Ralph A. Reisfeld, John M. Maris, Paul M. Sondel

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Integrative Genomics Identifies Distinct Molecular Classes of Neuroblastoma and Shows That Multiple Genes Are Targeted by Regional Alterations in DNA Copy Number

    Integrative Genomics Identifies Distinct Molecular Classes of Neuroblastoma and Shows That Multiple Genes Are Targeted by Regional Alterations in DNA Copy Number 由 Qun Wang, Sharon J. Diskin, Eric Rappaport, Edward F. Attiyeh, Yaël P. Mossé, Daniel Shue, Eric Seiser, Jayanti Jagannathan, Suzanne Shusterman, Manisha Bansal, Deepa Khazi, Cynthia Winter, Erin Okawa, Gregory R. Grant, Avital Cnaan, Huaqing Zhao, Nai‐Kong V. Cheung, William L. Gerald, Wendy B. London, Katherine K. Matthay, Garrett M. Brodeur, John M. Maris

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors

    Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors 由 Marian H. Harris, Steven G. DuBois, Julia Glade Bender, AeRang Kim, Brian D. Crompton, Erin Parker, Ian P. Dumont, Andrew L. Hong, Dongjing Guo, Alanna J. Church, Kimberly Stegmaier, Charles W.M. Roberts, Suzanne Shusterman, Wendy B. London, Laura E. MacConaill, Neal I. Lindeman, Lisa Diller, Carlos Rodríguez‐Galindo, Katherine A. Janeway

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

    Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Con... 由 Steven G. DuBois, Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Lingyun Ji, Anasheh Shamirian, Scarlett Czarnecki, Fariba Goodarzian, Rachel Berkovich, Hiroyuki Shimada, Judith G. Villablanca, Kieuhoa T. Vo, Navin Pinto, Yaël P. Mossé, John M. Maris, Suzanne Shusterman, Susan L. Cohn, Kelly C. Goldsmith, Brian Weiss, Gregory A. Yanik, Clare J. Twist, Meredith S. Irwin, Daphne A. Haas‐Kogan, Julie R. Park, Araz Marachelian, Katherine K. Matthay

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)

    Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG) 由 Ami V. Desai, Giles Robinson, Karen Gauvain, Ellen M. Basu, Margaret E. Macy, Luke Maese, Nicholas Whipple, Amit J. Sabnis, Jennifer H. Foster, Suzanne Shusterman, Janet Yoon, Brian Weiss, Mohamed S Abdelbaki, Amy E. Armstrong, Thomas F. Cash, Christine A. Pratilas, Nadège Corradini, Lynley V. Marshall, Mufiza Farid‐Kapadia, Saibah Chohan, Clare Devlin, Georgina Meneses‐Lorente, Alison K. Cardenas, Katherine E. Hutchinson, Guillaume Bergthold, Hubert Caron, Edna Chow Maneval, Amar Gajjar, Elizabeth Fox

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

    Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results 由 Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser, Jemily Malvar, Yueh‐Yun Chi, Susan Groshen, Judith G. Villablanca, Kateryna Krytska, Lillian M. Lai, Patricia T. Acharya, Fariba Goodarzian, Bruce Pawel, Hiroyuki Shimada, Susan Ghazarian, Lisa J. States, Lynley V. Marshall, Louis Chesler, Meaghan Granger, Ami V. Desai, Rajen Mody, Daniel A. Morgenstern, Suzanne Shusterman, Margaret E. Macy, Navin Pinto, Gudrun Schleiermacher, Kieuhoa T. Vo, Holger Thurm, Joseph Chen, Marlon Liyanage, Gerson Peltz, Katherine K. Matthay, Esther R. Berko, John M. Maris, Araz Marachelian, Yaël P. Mossé

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: